GE HealthCare Technologies Inc. (GEHC) earnings date, results and what the price requires
Nasdaq · SEC CIK 0001932393 · SEC filings checked Oct 19, 2026
Previous results (SEC filings)
| Quarter ended | Reported | Revenue | Net income | Diluted EPS | Source |
|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 23, 2026 | Announced; figures arrive with the 10-Q | — | — | Filing |
| Mar 31, 2026 | Apr 29, 2026 | $5.13B | $389.0M | $0.85 | Filing |
| Dec 31, 2025 | Feb 4, 2026 | $5.70B | $588.0M | $1.28 | Filing |
| Sep 30, 2025 | Oct 29, 2025 | $5.14B | $446.0M | $0.98 | Filing |
| Jun 30, 2025 | Jul 30, 2025 | $5.01B | $486.0M | $1.06 | Filing |
| Mar 31, 2025 | Apr 30, 2025 | $4.78B | $564.0M | $1.23 | Filing |
| Dec 31, 2024 | Feb 13, 2025 | $5.32B | $721.0M | $1.58 | Filing |
| Sep 30, 2024 | Oct 30, 2024 | $4.86B | $470.0M | $1.02 | Filing |
| Jun 30, 2024 | Jul 31, 2024 | $4.84B | $428.0M | $0.93 | Filing |
What would GE HealthCare Technologies Inc. have to report for its valuation to change?
At $69.57, with a 9.0% required return and a 18× earnings multiple in 5 years, earnings per share must grow about 7.4% a year, to $5.95. On that path the next quarter needs diluted EPS near $1.14, against $1.06 in the quarter ended Jun 30, 2025.
Compare buying at the last close now with waiting for results: if the report moves the growth the price requires, the entry price you would accept changes with it.
| Result | Original | Yours |
|---|---|---|
| Required EPS growth / year | 7.4% | 7.4% |
| EPS needed in final year | $5.95 | $5.95 |
Changed: nothing yet. Model: EPS × (1+g)^years × final P/E, discounted at the required return, equals today's price. Inputs: SEC diluted EPS and the dated close above.
Prepare for earnings across my investments — $399/month
Keep working models for the companies you follow, compare your expectations with reported results, and review what changes your investment decision. GEHC goes in with your buy-or-wait comparison and assumptions preserved.
Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.